ARTA
GTHX

A.R.T. Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

A.R.T. Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,912
Closed -$315K – 1067
2019
Q4 		$315K Buy
+11,912
New +$279K 0.02% 1015
2019
Q2 		– Sell
-55,038
Closed -$914K – 1689
2019
Q1 		$914K Buy
55,038
+16,913
+44% +$321K 0.05% 519
2018
Q4 		$730K Buy
38,125
+25,078
+192% +$939K 0.05% 558
2018
Q3 		$682K Sell
13,047
-10,185
-44% -$555K 0.03% 720
2018
Q2 		$1.01M Buy
23,232
+11,587
+100% +$496K 0.04% 632
2018
Q1 		$431K Buy
+11,645
New +$311K 0.02% 1013

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

A.R.T. Advisors's GTHX Position: Q1 2020 in Review

A.R.T. Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2020, closing a stake of 11,912 shares — an estimated $315K sold.

A.R.T. Advisors first reported a position in GTHX in Q1 2018 and held it in 6 quarters. The position peaked at $1.01M in Q2 2018. 100 funds tracked by Wall St. Rank hold GTHX as of Q1 2020.

  • A.R.T. Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 11,912 G1 Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $315K.
  • A.R.T. Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 6 quarters.
  • A.R.T. Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $1.01M in Q2 2018.
  • 100 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.